⌘K

Login Start Free

Home/Filings/4/0001493152-23-021563

4//SEC Filing

Trieu Vuong 4

Accession 0001493152-23-021563

CIK 0000908259other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 12:00 PM ET

Size

6.2 KB

Accession

0001493152-23-021563

Insider Transaction Report

Form 4

Period: 2023-06-14

Oncotelic Therapeutics, Inc.OTLC

DirectorCHAIRMAN AND CEO10% Owner

Transactions

Purchase
Common Stock
2023-06-14$0.03/sh+400,000$13,040→ 91,444,217 total

Holdings

Common Stock
(indirect: By Spouse)
6,872,529
Common Stock
(indirect: By Autotelic, Inc.)
16,780,384

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1

filerCIK 0001587074

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 12:00 PM ET
Size: 6.2 KB

View on SEC.gov